These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7013394)

  • 21. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age.
    Acerini CL; Cheetham TD; Edge JA; Dunger DB
    Diabetologia; 2000 Jan; 43(1):61-8. PubMed ID: 10663217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
    Taskinen MR; Groop L
    Ann Clin Res; 1984; 16(2):118-27. PubMed ID: 6380385
    [No Abstract]   [Full Text] [Related]  

  • 24. Postinitial remission in diabetic children--an analysis of 178 cases.
    Knip M; Säkkinen A; Huttunen NP; Käär ML; Länkelä S; Mustonen A; Akerblom HK
    Acta Paediatr Scand; 1982 Nov; 71(6):901-8. PubMed ID: 6760664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid Normalization of High Glutamic Acid Decarboxylase Autoantibody Titers and Preserved Endogenous Insulin Secretion in a Patient with Diabetes Mellitus: A Case Report and Literature Review.
    Ohara N; Kaneko M; Furukawa T; Koike T; Sone H; Tanaka S; Kaneko K; Kamoi K
    Intern Med; 2016; 55(5):485-9. PubMed ID: 26935368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin/glucagon relationship in spontaneous diabetic remission].
    Cresto JC; Sires JM; Ramos O; Abdenur JE; Basabe JC
    Medicina (B Aires); 1991; 51(3):195-203. PubMed ID: 1821901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin secretion in type 1 diabetes.
    Steele C; Hagopian WA; Gitelman S; Masharani U; Cavaghan M; Rother KI; Donaldson D; Harlan DM; Bluestone J; Herold KC
    Diabetes; 2004 Feb; 53(2):426-33. PubMed ID: 14747294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal ghrelin secretion in new onset childhood Type 1 diabetes.
    Holdstock C; Ludvigsson J; Karlsson FA
    Diabetologia; 2004 Jan; 47(1):150-1. PubMed ID: 14614562
    [No Abstract]   [Full Text] [Related]  

  • 29. [The period of initial remission in insulin-dependent diabetes. Effect of optimized insulin therapy].
    Vague P; Vialettes B; Lassmann V; Moulin JP
    Journ Annu Diabetol Hotel Dieu; 1984; ():73-84. PubMed ID: 6399541
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 31. Muscle capillary basement membrane in juvenile diabetes mellitus.
    Danowski TS; Fisher ER; Khurana RC; Nolan S; Stephan T
    Metabolism; 1972 Dec; 21(12):1125-32. PubMed ID: 4641955
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of taking charge and education on the remission of insulin-dependent diabetes].
    Bechir F; Ben Mansour A; Cotisson A; Bergaoui M; Blouza S; Ville G; Nagati KH
    Tunis Med; 1989 Nov; 67(11):703-7. PubMed ID: 2688229
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
    Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
    Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Residual insulin secretion in juvenile diabetes. Relationships with duration of diabetes, metabolic control and retinopathy (author's transl)].
    Dorchy H; Despontin M; Haumont D; Toussaint D; Loeb H
    Arch Fr Pediatr; 1982 Mar; 39(3):145-8. PubMed ID: 7049110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-peptide used in the estimation of islet beta-cell function in diabetes.
    Gjessing HJ
    Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818
    [No Abstract]   [Full Text] [Related]  

  • 36. Remission phase in newly diagnosed insulin treated juvenile diabetes: behaviour of glucose, FFA, HGH and total-IRI during combined glucose arginine infusion; development of antibodies against exogenous insulin.
    Menzel R; Michaelis D; Neumann I; Schultz B; Wilke W; Wulfert P; Michael R; Bibergeil H
    Endokrinologie; 1973 Aug; 62(1):100-6. PubMed ID: 4785266
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucose-stimulated insulin secretion during "remission" of juvenile diabetes.
    Weber B
    Diabetologia; 1972 Jul; 8(3):189-95. PubMed ID: 4625833
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P; Bonser A; Welborn TA
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemoglobin A1c levels in children and adolescents with diabetes mellitus.
    Goldstein DE; Walker B; Rawlings SS; Hess RL; England JD; Peth SB; Hewett JE
    Diabetes Care; 1980; 3(4):503-7. PubMed ID: 7006943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.
    Ortqvist E; Björk E; Wallensteen M; Ludvigsson J; Aman J; Johansson C; Forsander G; Lindgren F; Berglund L; Bengtsson M; Berne C; Persson B; Karlsson FA
    Diabetes Care; 2004 Sep; 27(9):2191-7. PubMed ID: 15333483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.